Antitumour necrosis factor α treatment reduces retinol-binding protein 4 serum levels in non-diabetic ankylosing spondylitis patients

Ann Rheum Dis. 2014 May;73(5):941-3. doi: 10.1136/annrheumdis-2013-204484. Epub 2013 Dec 9.
No abstract available

Keywords: Ankylosing Spondylitis; Anti-TNF; Atherosclerosis; Inflammation.

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antirheumatic Agents / therapeutic use*
  • Diabetes Mellitus
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Humans
  • Infliximab
  • Male
  • Retinol-Binding Proteins, Plasma / analysis*
  • Spondylitis, Ankylosing / blood*
  • Spondylitis, Ankylosing / drug therapy*
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • RBP4 protein, human
  • Retinol-Binding Proteins, Plasma
  • Tumor Necrosis Factor-alpha
  • Infliximab